Is Exposure Therapy Necessary to Treat PTSD?
13
[SD = 8.4], and Relaxation Therapy 3.8 years [SD = 4.4]). Patients could choose
male or female therapists (Markowitz et al., 2015).
The 110 study patients all had chronic PTSD and a minimum CAPS severity
score of 50— indicating at least moderately severe PTSD. None was taking
psychotropic
medication, and outside treatment was prohibited during the 14
weeks of the trial. The patients were highly traumatized and chronically ill
(Tables 1. 3 and 1. 4), racially and ethnically diverse, and had a mean age of
40.1 years. Only 15.5% were married or living with a partner, and only 36.4%
were employed full- time (10.9% were students). Ninety- three
percent reported
interpersonal traumas— which tend to cause greater distress than impersonal
traumas such as natural disasters (Kessler et al., 1995; Markowitz et al., 2009).
More than half (58%) of patients reported chronic trauma (mean duration since
primary trauma, 14.1 years [SD = 14.4]), including sexual (35%) and physical
(61%) abuse. Thirty- six percent reported childhood or adolescent traumas.
Three- quarters of patients had previously received psychotherapy, and nearly
half had received pharmacotherapy for PTSD (Markowitz et al., 2015).
Table 1. 4 describes patients’ psychiatric debility.
As anticipated, half had
current comorbid major depression; one- third reported having had multiple
depressive episodes. Nearly half met criteria for personality disorders, partic-
ularly paranoid,
obsessive- compulsive, and avoidant.
Patients assigned to Prolonged Exposure attended a mean of 8.3 sessions
(SD = 3.1) (a mean of 748 minutes [SD = 277] overall); IPT patients attended a
mean of 12.6 sessions (SD = 3.4) (a mean of 630 minutes [SD = 69] overall); and
Relaxation Therapy patients attended a mean 7.8 (SD = 3.5) sessions (a mean of
667 minutes [SD = 290] overall), or 83%, 90%, and 78% of prescribed sessions,
respectively.
Outcomes
CAPS scores substantially improved in each therapy over the 14- week course
of treatment (Table 1. 5), with large within- group pre- treatment– post- treatment
effect sizes (Cohen’s d):
for Prolonged Exposure,
d =
1.88; for IPT,
d =
1.69; and
for Relaxation Therapy,
d =
1.32. These changes indicate large reductions in PTSD
symptoms in all three treatments. The time- by- treatment interaction was not sig-
nificant. In comparison with Relaxation Therapy,
Prolonged Exposure showed a
significant advantage (
p
= 0.010), whereas IPT’s advantage fell short of statistical
significance (
p
= 0.097).
Crucially, the between- group difference in CAPS change
scores between Prolonged Exposure and IPT was 5.5 points, less than the 12.5- point
minimal inferiority threshold that we had defined
a priori. Thus the null hypo-
thesis of more than minimal inferiority of IPT was rejected (
p
= 0.035) (Table 1.5).
Table 1. 3.
Demographic Characteristics of Patients
with PTSD Receiving
Prolonged Exposure, IPT, or Relaxation Therapy
Do'stlaringiz bilan baham: